Literature DB >> 12527178

Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles.

Moses O Oyewumi1, Russell J Mumper.   

Abstract

Emulsifying wax and polyoxyl 2 stearyl ether (Brij 72) nanoparticles (2 mg/ml) containing high concentrations of gadolinium hexanedione (GdH) (0-3 mg) have been engineered from oil-in-water microemulsion templates. Solid nanoparticles were cured by cooling warm microemulsion templates (prepared at 55 degrees C) to room temperature in one vessel. Nanoparticles were characterized by transmission electron microscopy (TEM), photon correlation spectroscopy (PCS) and gel permeation chromatography (GPC). To obtain folate-coated nanoparticles, a folate ligand was added to either the microemulsion templates or nanoparticle suspensions at 25 degrees C. Since the concentration of Gd in the tumor is critical to the success of Gd-neutron capture therapy (NCT), the effects of various formulation factors on GdH entrapment in nanoparticles as well as tumor-targeting were studied. GdH entrapment in nanoparticles was affected mostly by the method of GdH incorporation and surfactant concentration used in preparing the microemulsion templates. Cell uptake studies were carried out in KB cells (human nasopharyngeal epidermal carcinoma cell line). The method of adding folate ligand to the formulations did not significantly affect nanoparticle cell uptake (P>0.11; t-test). However, the concentration of folate ligand added to nanoparticles had the greatest influence on nanoparticle uptake (P<0.01; t-test). The results showed that GdH entrapment and cell uptake were optimized and suggested that engineered folate-coated nanoparticles may serve as effective carrier systems for Gd-NCT of tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527178     DOI: 10.1016/s0378-5173(02)00587-2

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Size mapping of electric field-assisted production of polycaprolactone particles.

Authors:  M Enayati; Z Ahmad; E Stride; M Edirisinghe
Journal:  J R Soc Interface       Date:  2010-06-02       Impact factor: 4.118

2.  Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform.

Authors:  Sergio Sandoval; Natalie Mendez; Jesus G Alfaro; Jian Yang; Sharraya Aschemeyer; Alex Liberman; William C Trogler; Andrew C Kummel
Journal:  J Biomed Opt       Date:  2015-08       Impact factor: 3.170

3.  Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles.

Authors:  Esmaiel Jabbari; Xiaoming Yang; Seyedsina Moeinzadeh; Xuezhong He
Journal:  Eur J Pharm Biopharm       Date:  2012-12-27       Impact factor: 5.571

4.  Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.

Authors:  Mahesh D Chavanpatil; Ayman Khdair; Jayanth Panyam
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

5.  Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.

Authors:  Nabil F Saba; Xu Wang; Susan Müller; Mourad Tighiouart; Kwangjae Cho; Shuming Nie; Zhuo Chen; Dong M Shin
Journal:  Head Neck       Date:  2009-04       Impact factor: 3.147

6.  Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.

Authors:  Xuezhong He; Junyu Ma; Angel E Mercado; Weijie Xu; Esmaiel Jabbari
Journal:  Pharm Res       Date:  2008-01-15       Impact factor: 4.200

7.  Preliminary Study on Hepatocyte-Targeted Phosphorus-31 MRS Using ATP-Loaded Galactosylated Chitosan Oligosaccharide Nanoparticles.

Authors:  Ri-Sheng Yu; Xiu-Liang Zhu; Jian-Zhong Sun; Dan Shi; Ying Chen; Zhi-Kang Wang; Ke-Zhong Tang; Yong-Zhong Du
Journal:  Gastroenterol Res Pract       Date:  2013-12-02       Impact factor: 2.260

8.  Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI.

Authors:  Kevin Affram; Taylor Smith; Shannon Helsper; Jens T Rosenberg; Bo Han; Jose Trevino; Edward Agyare
Journal:  Cancer Nanotechnol       Date:  2020-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.